Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
Authors
Keywords
Chronic Kidney Disease, Chronic Kidney Disease Patient, Darbepoetin Alfa, Minimal Effective Concentration, TMDD Model
Journal
CLINICAL PHARMACOKINETICS
Volume 52, Issue 12, Pages 1063-1083
Publisher
Springer Nature
Online
2013-08-02
DOI
10.1007/s40262-013-0098-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose correction for the Michaelis–Menten approximation of the target-mediated drug disposition model
- (2012) Xiaoyu Yan et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Comparative Performance of Cell Life Span and Cell Transit Models for Describing Erythropoietic Drug Effects
- (2011) Nageshwar R. Budha et al. AAPS Journal
- Red Blood Cell Survival in Long-term Dialysis Patients
- (2011) Frederiek E. Vos et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The HIF Pathway and Erythrocytosis
- (2011) Frank S. Lee et al. Annual Review of Pathology-Mechanisms of Disease
- Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
- (2011) Bing-Bing Yang et al. CLINICAL PHARMACOKINETICS
- Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
- (2011) Liviawati Sutjandra et al. CLINICAL PHARMACOKINETICS
- Landmark advances in the development of erythropoietin
- (2011) James W Fisher EXPERIMENTAL BIOLOGY AND MEDICINE
- Population Pharmacokinetic and Pharmacodynamic Model-Based Comparability Assessment of a Recombinant Human Epoetin Alfa and the Biosimilar HX575
- (2011) Xiaoyu Yan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Population PK and IgE Pharmacodynamic Analysis of a Fully Human Monoclonal Antibody Against IL4 Receptor
- (2011) Tarundeep Kakkar et al. PHARMACEUTICAL RESEARCH
- Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects
- (2010) Yow-Ming C. Wang et al. AAPS Journal
- Twist and Shout: One Decade of Meta-Analyses of Erythropoiesis-Stimulating Agents in Cancer Patients
- (2010) Julia Bohlius et al. ACTA HAEMATOLOGICA
- Effects of CERA (continuous erythropoietin receptor activator) in patients with advanced non-small-cell lung cancer (NSCLC) receiving chemotherapy: results of a phase II study
- (2010) P. Gascon et al. ANNALS OF ONCOLOGY
- Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in anemic cancer patients
- (2010) Sihem Ait-Oudhia et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Absence of functional EpoR expression in human tumor cell lines
- (2010) S. Swift et al. BLOOD
- Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells
- (2010) A. M. Sinclair et al. BLOOD
- Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes
- (2010) J Glaspy et al. BRITISH JOURNAL OF CANCER
- Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact
- (2010) Zoltán Kiss et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The metabolism of erythropoietin in liver cirrhosis patients compared with healthy volunteers.
- (2010) J.D. Jensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Population Pharmacokinetic/Pharmacodynamic Model for C.E.R.A. in Both ESA-Naïve and ESA-Treated Chronic Kidney Disease Patients With Renal Anemia
- (2010) Pascal Chanu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Exposure-Response Modeling of Darbepoetin Alfa in Anemic Patients With Chronic Kidney Disease Not Receiving Dialysis
- (2010) Sameer Doshi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Evidence of Receptor-Mediated Elimination of Erythropoietin by Analysis of Erythropoietin Receptor mRNA Expression in Bone Marrow and Erythropoietin Clearance During Anemia
- (2010) D. Nalbant et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacodynamic Analysis of Recombinant Human Erythropoietin Effect on Reticulocyte Production Rate and Age Distribution in Healthy Subjects
- (2009) Juan José Pérez-Ruixo et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody™ Construct CNTO 528 in Healthy Subjects
- (2009) Juan José Pérez-Ruixo et al. CLINICAL PHARMACOKINETICS
- Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells
- (2009) Steve Elliott et al. JOURNAL OF IMMUNOLOGICAL METHODS
- C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis: Results of a Randomized Clinical Trial
- (2008) I. C. Macdougall et al. Clinical Journal of the American Society of Nephrology
- Erythropoietins: A common mechanism of action
- (2008) Steve Elliott et al. EXPERIMENTAL HEMATOLOGY
- Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role
- (2008) Balaji Agoram et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers
- (2007) Sukyung Woo et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now